Evie Headlam
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Genetics top 10%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 1
- Genetics 4
- Genetic Associations and Epidemiology 4
In The Last Decade
Evie Headlam
7 papers receiving 583 citations
Evie Headlam's Hit Papers
Peers
Comparison fields: 5 of 56
- Infectious Diseases 235
- Genetics 193
- Pharmacology 57
- Applied Microbiology and Biotechnology 8
- Immunology 46
Countries citing papers authored by Evie Headlam
This map shows the geographic impact of Evie Headlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evie Headlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evie Headlam more than expected).
Fields of papers citing papers by Evie Headlam
This network shows the impact of papers produced by Evie Headlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evie Headlam. The network helps show where Evie Headlam may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 2 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 3 | Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis Hit paper breakdown → | 2024 | 94 |
| 4 | 2023 | 60 | |
| 5 | 2023 | 46 | |
| 6 | 2023 | 34 | |
| 7 | 2024 | 8 |
About Evie Headlam
Evie Headlam is a scholar working on Infectious Diseases, Genetics, Nutrition and Dietetics, Pharmacology and Nuclear Energy and Engineering, having authored 7 papers that have together received 600 indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (4 papers), COVID-19 Clinical Research Studies (3 papers), Vitamin C and Antioxidants Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Infectious Diseases (235 citations), Genetics (193 citations), Pharmacology (57 citations), Applied Microbiology and Biotechnology (8 citations) and Immunology (46 citations). Their work appears in journals such as Nature, JAMA and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.